Hope for Age Related Macular Degeneration with Lucentis
Saturday, December 31st, 2005Genentech Inc. has applied for U.S. (FDA) approval to market its drug Lucentis for the treatment of wet, age-related macular degeneration, the leading causes of blindness in the elderly.
































